Lumena Pharmaceuticals (LIVR) Acquired

Clinical-stage biotech developing candidates for rare liver diseases including NASH.

Other -

IPO Performance
Latest Trade ()
First Day Return
Return from IPO
 
Lumena Pharmaceuticals IPO News more
  • .
IPO Data
IPO File Date 04/02/2014
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $75
 
IPO Data
IPO Date
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $$75
 
Underwriters
more
Business Overview
Clinical-stage biotech developing candidates for rare liver diseases including NASH.
Clinical-stage biotech developing candidates for rare liver diseases including NASH.
more
Company Data
Headquarters San Diego, CA
Founded 2011
Employees 17
Website www.lumenapharma.com
 

Performance vs. IPO Index (IPOUSA)